Reversing Cognitive Decline: Groundbreaking Results from a Randomized Controlled Trial of Precision Medicine in Alzheimer’s Disease
This presentation will discuss the exciting results from our randomized controlled trial using a personalized, multimodal precision medicine approach to reverse mild cognitive impairment and early Alzheimer's. The session will provide a practical roadmap for physicians seeking to move beyond monotherapeutic models and implement precision brain health strategies within their own practices.

.jpg.png)
